以上来源于: WordNet
Last year, Cipla also slashed prices in India on its cancer medicines by up to 63%.
WSJ: Novartis Loses Glivec Patent Battle in India
Several produce and sell generics overseas--like Yusuf Hamied, who heads leading generics producer Cipla.
FORBES: India's Richest Businesspeople
Meanwhile Bayer is fending off another competitor, Cipla, which has sold generic Nexavar in India for years.
ECONOMIST: Indian drug patents: Taking pains | The
应用推荐
模块上移
模块下移
不移动